Navigation Links
Baxter International Second Quarter 2008 Financial Results Conference Call
Date:7/14/2008

DEERFIELD, Ill., July 14 /PRNewswire-FirstCall/ -- Baxter International (NYSE: BAX), will host a quarterly conference call to discuss its second quarter 2008 financial results on Thursday, July 17, 2008, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). To access the call, please dial 866-238-0637 (domestic) or 703-639-1156 (international). Please dial into the call at least ten minutes prior to the start of the call for the operator to connect you.

This call is being webcast by Thomson/CCBN and can be accessed at Baxter's Web site at http://www.baxter.com/ . The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission.

The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at http://www.earnings.com , Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents ( http://www.streetevents.com ), a password-protected event management site.

Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with the treatment of complex medical conditions, including cancer, hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other medical conditions. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.

Contact Information:

Investor Relations Contact

Mary Kay Ladone, +1-847-948-3371

Mary_Kay_Ladone@baxter.com

Clare Trachtman, +1-847-948-3085

Clare_Trachtman@baxter.com


'/>"/>
SOURCE Baxter International
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Baxter Releases Ninth Annual Sustainability Report
2. John D. Baxter, M.D. Joins Bionovos Board of Directors
3. FDA Finds Contaminant in Baxters Recalled Heparin Products
4. Baxter Recalls Rest of Heparin Products
5. Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
6. Baxter Reports Strong Third Quarter Sales and Earnings
7. Baxter International Third Quarter 2007 Financial Results Conference Call
8. HUB International New England Reminds Massachusetts Boaters that Safety is Paramount This Summer
9. First International Cancer Film Festival Announces Finalists
10. Chindex International, Inc. Announces CDC Contract Signing
11. HHS Announces New International Programs to Enhance Drug and Food Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... 23, 2017 , ... The Wound Certification Prep Course ... Holdings, LLC, today announced that RestorixHealth® has officially endorsed WCPC as ... interested in becoming Certified Wound Specialist Physicians (CWSP®). , This collaborative effort ...
(Date:3/23/2017)... ... March 23, 2017 , ... Altec Products, Inc. , ... as their 2016 Microsoft Dynamics Partner of the Year at DocLink Evolution ... award recognizes The Resource Group for their outstanding relationship with Altec and their ...
(Date:3/23/2017)... FL (PRWEB) , ... March 23, 2017 , ... ... dietary supplements that help improve all aspects of people’s health and nutrition, announced ... for nutritional products. , Natural Subsistence develops nutritional supplements that help people ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... all Americans facing life-altering and fatal diseases in opposition to the President’s ... that would eviscerate care, services, and hope for the most vulnerable among us. ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... audit software solution, iCode Assurance, at HCCA’s 21st annual Compliance Institute on March ... the coding audit process for all medical chart types with a comprehensive set ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 2017  Ethicon* today announced the completion of ... held medical device company that manufactures and markets ... treatment of Gastroesophageal Reflux Disease (GERD). This acquisition ... portfolio of minimally invasive options for patients suffering ... of the transaction have not been disclosed. ...
(Date:3/23/2017)... A research report by Mordor Intelligence ... reach USD 7.2 billion by the end of 2021 and ... procedure in which a sample is preserved prior to its ... since the methods are often allowing repeated testing. The report ... shared procedures in the lab. In many life science labs, ...
(Date:3/23/2017)... 2017  Drug diversion is a significant contributing ... overdoses. A new oral fluid monitoring test, announced ... reports more detailed and actionable information to clinicians ... therapy adherence, patient safety, and help to identify ... fluid Rx Evaluation (CORE) system is the first ...
Breaking Medicine Technology: